BioProcess International Announces Finalists for the 2016 BioProcess International Awards

The finalists for the 2016 BioProcess International Awards have been announced. The Awards ceremony will be Oct. 5, 2016 at Biotech Week Boston.

BPI Staff

September 15, 2016

5 Min Read
BioProcess International Announces Finalists for the 2016 BioProcess International Awards

BioProcess International (BPI), the biopharmaceutical industry’s leading business-to-business publication, today announced the finalists for the 2016 BioProcess International Awards. The awards celebrate the outstanding individual and team achievements, recognize emerging companies and their technologies, highlight groundbreaking business collaborations and strategies, corporate responsibility and technology applications that will allow the industry to deliver better, more effective treatments to a global patient base. Award winners and finalists, individually voted on and ranked by the 2016 BPI Awards Judging committee from 125+ nominations from around the world, will be recognized at a special dinner and ceremony during the 2016 BioProcess International Conference on Wednesday, 5 October 2016, at the Boston Convention and Exhibition Center in Boston, MA.

“The BioProcess International Award program has come to represent the very best this industry has to offer. In 2016, a record number of submitted nominations ensures that this group of BPI Award finalists reflects and represents the dedication, innovation and imagination embodied by this industry as a whole,” said Brian Caine, Co-Founder and Publisher of BioProcess International. “Congratulations to all the nominees and finalists. On October 5, 2016, at the BioProcess International Conference, we look forward to introducing the 2016 BioProcess International Award winners and their incredible achievements.”

Award categories and finalists (in alphabetical order) appear below. For more information on the finalists and the 2016 BioProcess International Industry Champion, please visit

BioProcess International 2016 Award Finalists

Excellence in Leadership
Recognizes any single individual in a company whose leadership skills have allowed them to successfully help their businesses achieve operational excellence.

  • Dr. Marcel Bassil, Associate Director, Biotech, Benta SAL

  • Dr. Igor Fisch, Chief Executive Officer, Selexis

  • Olivier Loeillot, General Manager, GE Healthcare

Emerging Company
Recognizes the companies to watch! New science, new technologies that have seen significant industry adoption with the chance to change the status-quo.

  •     Cell and Gene Therapy Catapult * Cell Therapy

  •     NuMedii * Digital Health

  •     Quad Technologies * Cell Therapy

Corporate Citizenship
Recognizes companies that have made unique and significant contributions to the local, regional, and global community.

  •     Baxter – The Baxter International Foundation

  •     Biogen – Closing the Hemophilia Gap in the Developing World

  •     GlaxoSmithKline – The PULSE Partnership

Excellence in Facility Design or Retrofit
Recognizes a facility that exemplifies innovation through the use of key technologies and/or designs.

  •     FUJIFILM DioSynth – Re-Purposing a Microbial facility for Multi-Product GMP Manufacturing

  •     Gibraltar Laboratories – cGMP Independent Lab and Sterilization Services

  •     JHL Biotech – Installation of KUBio Biomanufacturing Solution

Best Collaboration
Partnerships that have proven to result in significant benefits toward accelerating drug development.

  •     G-CON/GEA Pharma Systems/Pfizer – The PCMM Consortium

  •     Pall Life Sciences/FloDesign – Disruptive Cadence Acoustic Separator

  •     Puridify/GSK – FibroSelect Industrial Use

Best Technology Application – Upstream
User or supplier of an application that has demonstrated significant adoption, process improvements and documented results.

  •     Nova Biomedical – BioProfile FLEX2

  •     Glycotope – SAM – Perfusion in an Ambr System

  •     Stratophase – Ranger Service

Best Technology Application – Downstream
User or supplier that has been able to demonstrate reduction in downstream processing steps, time, and cost.

  •     Pall Life Sciences – Cadence Acoustic Separator

  •     Puridify – FibroSelect

  •     Sanofi – Continuous Disposable Technology

Best Technology Application – Analytical
User or supplier has demonstrated increased functionality in novel combinations with other analytical technologies.

  •     Catalent Pharma Solutions – Bio-Layer Interferometry (Octet)

  •     Ovizio – iLine F

  •     Sciex – High Throughput Glycoslyation Analysis

BPI’s 2016 Industry Champion

  •     Mark Petrich – Director, Single-Use Systems Engineering, Merck

BioProcess Awards Ceremony & Dinner –
Wednesday October 5, 2016, from 7:00pm-10:00pm
As part of Biotech Week Boston held Oct 4-7, 2016, the 2016 BioProcess International Awards dinner will honor the individuals, organizations and technologies that have significantly impacted, and advanced the efficiency of biotherapeutic development and manufacturing process.

A special offer for a three-day exhibit hall pass to Biotech Week Boston, along with a ticket to the BioProcess Awards Ceremony & Dinner is available for $299. Use VIP Code BIOPR299 to register online by September 30, 2016.

About the 2016 BioProcess International Awards Sponsors

GE Healthcare’s Life Sciences business provides a wide range of bioprocessing solutions for the development and manufacture of high-quality biotherapeutics and vaccines. Using our expertise, we support our customers in increasing speed to market, while reducing costs and improving performance in drug manufacturing. As a provider of high-quality products, technical and commercial services, as well as design and construction of complete biomanufacturing solutions, we support the biopharmaceutical industry in making health visions a reality.

Pall Life Sciences is the leading global provider of filtration, purification and separation products and technologies to the diverse and rapidly expanding biopharmaceuticals market. These products and technologies are used from the earliest stages of discovery and development of new drugs, through production and delivery of therapies for the prevention, diagnosis and treatment of disease. Our biopharmaceutical products are supported by extensive protocols and technical reports, an industry-leading scientific and technical staff, and worldwide offices and distributors for easy ordering.

JSR Life Sciences is a business unit of JSR Corporation, a global company built on more than 50 years of performance material expertise and it began research in the life sciences field more than 30 years ago.
We are continually developing highly functional materials and products to meet the current and future needs of the growing biotechnology industry. Using a variety of integrated, leading-edge technologies, JSR Life Sciences provides materials that contribute to the manufacturing process of biopharmaceuticals, life science research applications, in vitro diagnostics and medical devices. JSR Life Sciences has offices, laboratories and manufacturing facilities in Tokyo and Tsukuba (JP), Sunnyvale (CA, USA), Leuven (BE), and Beijing (CN).    

WuXi Biologics. As a premier Contract Discovery, Development and Manufacturing Organization (CDMO), WuXi Biologics provides our clients worldwide with the necessary expertise, quality and capacities to develop biologic drugs from idea to market. Along with our WuXi AppTec affiliates, we provide the world with the ONE true single-source approach that saves our clients critical time and money.

2016 BioProcess International Awards Partners

BioProcess International would like to thank and recognize the following industry partners who help make this event successful

Bio-Process Systems Alliance
Women in Bio
Biotechnology Innovation Organization
Biomanufacturing Training and Education Center

To view award program details, please visit:

You May Also Like